Daré Bioscience (NASDAQ:DARE) Share Price Crosses Above Fifty Day Moving Average – Time to Sell?

Shares of Daré Bioscience, Inc. (NASDAQ:DARE) passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $3.36 and traded as high as $3.38. Daré Bioscience shares last traded at $3.33, with a volume of 49,228 shares.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright restated a “buy” rating and issued a $12.00 price objective on shares of Daré Bioscience in a report on Tuesday, December 17th.

Daré Bioscience Stock Performance

The stock’s 50-day simple moving average is $3.36 and its 200 day simple moving average is $3.43. The company has a market capitalization of $28.97 million, a PE ratio of -5.64 and a beta of 1.28.

Institutional Investors Weigh In On Daré Bioscience

A hedge fund recently raised its stake in Daré Bioscience stock. Renaissance Technologies LLC raised its position in Daré Bioscience, Inc. (NASDAQ:DARE) by 2.1% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 778,700 shares of the biotechnology company’s stock after purchasing an additional 15,800 shares during the period. Renaissance Technologies LLC owned 9.25% of Daré Bioscience worth $262,000 as of its most recent filing with the Securities and Exchange Commission. 6.70% of the stock is currently owned by hedge funds and other institutional investors.

About Daré Bioscience

Daré Bioscience, Inc, a biopharmaceutical company, identifies, develops, and markets products for women's health in the United States. It develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health. The company offers XACIATO for the treatment of bacterial vaginosis in female patients 12 years of age and older.